RU2318818C1 - Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) - Google Patents
Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) Download PDFInfo
- Publication number
- RU2318818C1 RU2318818C1 RU2006111951/04A RU2006111951A RU2318818C1 RU 2318818 C1 RU2318818 C1 RU 2318818C1 RU 2006111951/04 A RU2006111951/04 A RU 2006111951/04A RU 2006111951 A RU2006111951 A RU 2006111951A RU 2318818 C1 RU2318818 C1 RU 2318818C1
- Authority
- RU
- Russia
- Prior art keywords
- general formula
- possibly
- compounds
- substituted
- bonded
- Prior art date
Links
- 0 COc1cc(CN)ccc1* Chemical compound COc1cc(CN)ccc1* 0.000 description 30
- VWQDTDSEZQLGEI-UHFFFAOYSA-N CC(C(C=C1)OC)C(C(C)=O)=C1C1=C(C(O)=O)SCC1 Chemical compound CC(C(C=C1)OC)C(C(C)=O)=C1C1=C(C(O)=O)SCC1 VWQDTDSEZQLGEI-UHFFFAOYSA-N 0.000 description 1
- AGVCHZQIKXSZAM-UHFFFAOYSA-N CC(C(N(Cc1ccccc1)C1C(NC2CCCCC2)=O)=O)NC1=O Chemical compound CC(C(N(Cc1ccccc1)C1C(NC2CCCCC2)=O)=O)NC1=O AGVCHZQIKXSZAM-UHFFFAOYSA-N 0.000 description 1
- MOWNDMZGRPLXHJ-UHFFFAOYSA-N CC(C)(CCS(NC1)(=O)=O)N(C)C1=O Chemical compound CC(C)(CCS(NC1)(=O)=O)N(C)C1=O MOWNDMZGRPLXHJ-UHFFFAOYSA-N 0.000 description 1
- WQPSKUFCLIULPZ-UHFFFAOYSA-N CC(C1C(C)C=C(C2)C(C3)C2CC3C1)N Chemical compound CC(C1C(C)C=C(C2)C(C3)C2CC3C1)N WQPSKUFCLIULPZ-UHFFFAOYSA-N 0.000 description 1
- HKXRWDBEMDCHPE-UHFFFAOYSA-N CC(CC(C1c(cccc2)c2N(C)C1C(O)=O)c1ccccc1)=O Chemical compound CC(CC(C1c(cccc2)c2N(C)C1C(O)=O)c1ccccc1)=O HKXRWDBEMDCHPE-UHFFFAOYSA-N 0.000 description 1
- KSMVBYPXNKCPAJ-UHFFFAOYSA-N CC(CC1)CCC1N Chemical compound CC(CC1)CCC1N KSMVBYPXNKCPAJ-UHFFFAOYSA-N 0.000 description 1
- UNROKQYQOLRLMP-UHFFFAOYSA-N CC(CCC(N(C)CC1)=C(C(O)=O)C1=O)=O Chemical compound CC(CCC(N(C)CC1)=C(C(O)=O)C1=O)=O UNROKQYQOLRLMP-UHFFFAOYSA-N 0.000 description 1
- LKWOOKWVBNSLGN-UHFFFAOYSA-N CC(CCC1)C(C)C1N Chemical compound CC(CCC1)C(C)C1N LKWOOKWVBNSLGN-UHFFFAOYSA-N 0.000 description 1
- XURAWSDBQCALFO-UHFFFAOYSA-N CC(CCC1N(C)c2ccccc2C1C(O)=O)=O Chemical compound CC(CCC1N(C)c2ccccc2C1C(O)=O)=O XURAWSDBQCALFO-UHFFFAOYSA-N 0.000 description 1
- FEUISMYEFPANSS-UHFFFAOYSA-N CC(CCCC1)C1N Chemical compound CC(CCCC1)C1N FEUISMYEFPANSS-UHFFFAOYSA-N 0.000 description 1
- KBBPKIHLEHPFEW-UHFFFAOYSA-N CC(CCc(nccc1)c1C(O)=O)=O Chemical compound CC(CCc(nccc1)c1C(O)=O)=O KBBPKIHLEHPFEW-UHFFFAOYSA-N 0.000 description 1
- MAUWPXMXZNTZRH-UHFFFAOYSA-N CC(CCc1c(C(O)=O)[s]c(C)c1C)O Chemical compound CC(CCc1c(C(O)=O)[s]c(C)c1C)O MAUWPXMXZNTZRH-UHFFFAOYSA-N 0.000 description 1
- DUFXGGFKZDXKGG-UHFFFAOYSA-N CC(CCc1c(C(O)=O)[s]c2c1c(OC)ncn2)=O Chemical compound CC(CCc1c(C(O)=O)[s]c2c1c(OC)ncn2)=O DUFXGGFKZDXKGG-UHFFFAOYSA-N 0.000 description 1
- QPNCPICLAFVJJI-UHFFFAOYSA-N CC(CCc1c(C(O)=O)[s]c2c1cccc2)=O Chemical compound CC(CCc1c(C(O)=O)[s]c2c1cccc2)=O QPNCPICLAFVJJI-UHFFFAOYSA-N 0.000 description 1
- QTAFLCHGIXLKJK-UHFFFAOYSA-N CC(CCc1c(C(O)=O)[s]c2c1nc(C)[s]2)=O Chemical compound CC(CCc1c(C(O)=O)[s]c2c1nc(C)[s]2)=O QTAFLCHGIXLKJK-UHFFFAOYSA-N 0.000 description 1
- LDFRAZNRPMGJIF-UHFFFAOYSA-N CC(CCc1c(C(O)=O)c(C)c(C)[o]1)=O Chemical compound CC(CCc1c(C(O)=O)c(C)c(C)[o]1)=O LDFRAZNRPMGJIF-UHFFFAOYSA-N 0.000 description 1
- MVUDAIRHSGVDGC-UHFFFAOYSA-N CC(c([n](C)nc1C(F)(F)F)c1-c1c(C(O)=O)[s]cc1)=O Chemical compound CC(c([n](C)nc1C(F)(F)F)c1-c1c(C(O)=O)[s]cc1)=O MVUDAIRHSGVDGC-UHFFFAOYSA-N 0.000 description 1
- FVSPLOGYWZJXPP-UHFFFAOYSA-N CC(c([s]cc1)c1-c1c(C(O)=O)[s]cc1)=O Chemical compound CC(c([s]cc1)c1-c1c(C(O)=O)[s]cc1)=O FVSPLOGYWZJXPP-UHFFFAOYSA-N 0.000 description 1
- YLJRDADSOUSKLZ-UHFFFAOYSA-N CC(c(c(-c1c(C(O)=O)[s]cc1)c1)ccc1O)=O Chemical compound CC(c(c(-c1c(C(O)=O)[s]cc1)c1)ccc1O)=O YLJRDADSOUSKLZ-UHFFFAOYSA-N 0.000 description 1
- PTBSWBARPWZCNN-UHFFFAOYSA-N CC(c(c(C1C=CSC1C(O)=O)c1)cc2c1OCCO2)=O Chemical compound CC(c(c(C1C=CSC1C(O)=O)c1)cc2c1OCCO2)=O PTBSWBARPWZCNN-UHFFFAOYSA-N 0.000 description 1
- YBGBKVQXYJRVGV-UHFFFAOYSA-N CC(c1cc(F)ccc1C1C=CSC1C(O)=O)=O Chemical compound CC(c1cc(F)ccc1C1C=CSC1C(O)=O)=O YBGBKVQXYJRVGV-UHFFFAOYSA-N 0.000 description 1
- ABUSRLBOAUOYSM-UHFFFAOYSA-N CC(c1ccc2OCCOc2c1)N Chemical compound CC(c1ccc2OCCOc2c1)N ABUSRLBOAUOYSM-UHFFFAOYSA-N 0.000 description 1
- NKRJZPBOKZERKZ-UHFFFAOYSA-N CC(c1ccccc1)N1CNC(CN)C1 Chemical compound CC(c1ccccc1)N1CNC(CN)C1 NKRJZPBOKZERKZ-UHFFFAOYSA-N 0.000 description 1
- SPEVZWROSYRJDK-UHFFFAOYSA-N CC(c1n[n](C)cc1-c1c(C(O)=O)[s]cc1)=O Chemical compound CC(c1n[n](C)cc1-c1c(C(O)=O)[s]cc1)=O SPEVZWROSYRJDK-UHFFFAOYSA-N 0.000 description 1
- XKMIUYSPJWTYCW-UHFFFAOYSA-N CC1(CCC2c3ccccc3OC2C(O)=O)OC1 Chemical compound CC1(CCC2c3ccccc3OC2C(O)=O)OC1 XKMIUYSPJWTYCW-UHFFFAOYSA-N 0.000 description 1
- UNRBEYYLYRXYCG-UHFFFAOYSA-N CCN1C(CN)CCC1 Chemical compound CCN1C(CN)CCC1 UNRBEYYLYRXYCG-UHFFFAOYSA-N 0.000 description 1
- GQQQULCEHJQUJT-UHFFFAOYSA-N CCOC(N(CC1)CCC1N)=O Chemical compound CCOC(N(CC1)CCC1N)=O GQQQULCEHJQUJT-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N CCOC(c(cc1)ccc1N)=O Chemical compound CCOC(c(cc1)ccc1N)=O BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- DGAGEFUEKIORSQ-UHFFFAOYSA-N CCc1ccc(CN)cc1 Chemical compound CCc1ccc(CN)cc1 DGAGEFUEKIORSQ-UHFFFAOYSA-N 0.000 description 1
- XPOSMRFZDCJJIY-UHFFFAOYSA-N CN(CC=C(C(N)=O)N1C)CC1=O Chemical compound CN(CC=C(C(N)=O)N1C)CC1=O XPOSMRFZDCJJIY-UHFFFAOYSA-N 0.000 description 1
- FTYHXFNQBPNXDD-UHFFFAOYSA-N CN(CCC(O)=O)Cc1c(C=O)cccc1 Chemical compound CN(CCC(O)=O)Cc1c(C=O)cccc1 FTYHXFNQBPNXDD-UHFFFAOYSA-N 0.000 description 1
- LNFVNSDBZOLCQV-UHFFFAOYSA-N CN(Cc1c(C=O)cccc1)C(CC(O)=O)c1ccccc1 Chemical compound CN(Cc1c(C=O)cccc1)C(CC(O)=O)c1ccccc1 LNFVNSDBZOLCQV-UHFFFAOYSA-N 0.000 description 1
- UGQFOJVOTFYQRH-UHFFFAOYSA-N CN(Cc1c(C=O)cccc1)c1ccccc1C(O)=O Chemical compound CN(Cc1c(C=O)cccc1)c1ccccc1C(O)=O UGQFOJVOTFYQRH-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N COc1ccc(CN)cc1 Chemical compound COc1ccc(CN)cc1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- ROHDZTKPJVAVDL-SSDOTTSWSA-N C[C@H](CC(NC1)=O)C(C)(C)N(C)C1=O Chemical compound C[C@H](CC(NC1)=O)C(C)(C)N(C)C1=O ROHDZTKPJVAVDL-SSDOTTSWSA-N 0.000 description 1
- MKUWKNFLLPMKTA-UHFFFAOYSA-N Cc(cc1)ccc1C(CCCNc1n[nH]cc1C(O)=O)=O Chemical compound Cc(cc1)ccc1C(CCCNc1n[nH]cc1C(O)=O)=O MKUWKNFLLPMKTA-UHFFFAOYSA-N 0.000 description 1
- UUYAVDNORSEOKV-UHFFFAOYSA-N Cc(cc1)nc(OCc2cnc(C)c(O)c2C=O)c1C(O)=O Chemical compound Cc(cc1)nc(OCc2cnc(C)c(O)c2C=O)c1C(O)=O UUYAVDNORSEOKV-UHFFFAOYSA-N 0.000 description 1
- CZZZABOKJQXEBO-UHFFFAOYSA-N Cc(cc1C)ccc1N Chemical compound Cc(cc1C)ccc1N CZZZABOKJQXEBO-UHFFFAOYSA-N 0.000 description 1
- XGYLSRFSXKAYCR-UHFFFAOYSA-N Cc(cc1Cl)ccc1N Chemical compound Cc(cc1Cl)ccc1N XGYLSRFSXKAYCR-UHFFFAOYSA-N 0.000 description 1
- WXWCDTXEKCVRRO-UHFFFAOYSA-N Cc(cc1N)ccc1OC Chemical compound Cc(cc1N)ccc1OC WXWCDTXEKCVRRO-UHFFFAOYSA-N 0.000 description 1
- DSANXQSOURENBZ-UHFFFAOYSA-N Cc(ncc(COc(nc(cc1)Cl)c1C(O)=O)c1C=O)c1O Chemical compound Cc(ncc(COc(nc(cc1)Cl)c1C(O)=O)c1C=O)c1O DSANXQSOURENBZ-UHFFFAOYSA-N 0.000 description 1
- AWMRDGSVGBQVMS-UHFFFAOYSA-N Cc(ncc(COc(nccc1)c1C(O)=O)c1C=O)c1O Chemical compound Cc(ncc(COc(nccc1)c1C(O)=O)c1C=O)c1O AWMRDGSVGBQVMS-UHFFFAOYSA-N 0.000 description 1
- KMHLGVTVACLEJE-UHFFFAOYSA-N Cc1cc(F)ccc1N Chemical compound Cc1cc(F)ccc1N KMHLGVTVACLEJE-UHFFFAOYSA-N 0.000 description 1
- VOWZNBNDMFLQGM-UHFFFAOYSA-N Cc1ccc(C)c(N)c1 Chemical compound Cc1ccc(C)c(N)c1 VOWZNBNDMFLQGM-UHFFFAOYSA-N 0.000 description 1
- HMTSWYPNXFHGEP-UHFFFAOYSA-N Cc1ccc(CN)cc1 Chemical compound Cc1ccc(CN)cc1 HMTSWYPNXFHGEP-UHFFFAOYSA-N 0.000 description 1
- JHJSPOWOZORBLM-UHFFFAOYSA-N Cc1ccc(CN2CCC(CN)CC2)cc1 Chemical compound Cc1ccc(CN2CCC(CN)CC2)cc1 JHJSPOWOZORBLM-UHFFFAOYSA-N 0.000 description 1
- RNVCVTLRINQCPJ-UHFFFAOYSA-N Cc1ccccc1N Chemical compound Cc1ccccc1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 1
- GEZWMXMCXOIIJG-UHFFFAOYSA-N Cc1ncc(COc(cccc2)c2C(O)=O)c(C=O)c1O Chemical compound Cc1ncc(COc(cccc2)c2C(O)=O)c(C=O)c1O GEZWMXMCXOIIJG-UHFFFAOYSA-N 0.000 description 1
- UBMKOYKGXCWZMY-UHFFFAOYSA-N NC(C(C[n]1c2ccc1)NC2=O)=O Chemical compound NC(C(C[n]1c2ccc1)NC2=O)=O UBMKOYKGXCWZMY-UHFFFAOYSA-N 0.000 description 1
- GUWJWHVRFYGXLQ-UHFFFAOYSA-N NC(C(c(c(cccc1)c1cc1)c1OC1)NC1=O)=O Chemical compound NC(C(c(c(cccc1)c1cc1)c1OC1)NC1=O)=O GUWJWHVRFYGXLQ-UHFFFAOYSA-N 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N NC1CCCC1 Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N NC1CCCCC1 Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 1
- YUBDLZGUSSWQSS-UHFFFAOYSA-N NC1CCN(Cc2ccccc2)CC1 Chemical compound NC1CCN(Cc2ccccc2)CC1 YUBDLZGUSSWQSS-UHFFFAOYSA-N 0.000 description 1
- JRZGPXSSNPTNMA-UHFFFAOYSA-N NC1c2ccccc2CCC1 Chemical compound NC1c2ccccc2CCC1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 description 1
- YNOGYQAEJGADFJ-UHFFFAOYSA-N NCC1OCCC1 Chemical compound NCC1OCCC1 YNOGYQAEJGADFJ-UHFFFAOYSA-N 0.000 description 1
- JHNURUNMNRSGRO-UHFFFAOYSA-N NCC1Oc(cccc2)c2OC1 Chemical compound NCC1Oc(cccc2)c2OC1 JHNURUNMNRSGRO-UHFFFAOYSA-N 0.000 description 1
- RCHOKTKXVKKNBC-UHFFFAOYSA-N NCc(c(F)cc(F)c1)c1F Chemical compound NCc(c(F)cc(F)c1)c1F RCHOKTKXVKKNBC-UHFFFAOYSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N NCc(cc1)ccc1Cl Chemical compound NCc(cc1)ccc1Cl YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N NCc(cc1)ccc1F Chemical compound NCc(cc1)ccc1F IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 1
- CBKWAXKMZUULLO-UHFFFAOYSA-N NCc(ccc(F)c1)c1Cl Chemical compound NCc(ccc(F)c1)c1Cl CBKWAXKMZUULLO-UHFFFAOYSA-N 0.000 description 1
- ZILSBZLQGRBMOR-UHFFFAOYSA-N NCc1ccc2OCOc2c1 Chemical compound NCc1ccc2OCOc2c1 ZILSBZLQGRBMOR-UHFFFAOYSA-N 0.000 description 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N NCc1ccc[o]1 Chemical compound NCc1ccc[o]1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 1
- FKKJJPMGAWGYPN-UHFFFAOYSA-N NCc1ccc[s]1 Chemical compound NCc1ccc[s]1 FKKJJPMGAWGYPN-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N NCc1ccccn1 Chemical compound NCc1ccccn1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- HDOUGSFASVGDCS-UHFFFAOYSA-N NCc1cccnc1 Chemical compound NCc1cccnc1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 1
- GZRMNMGWNKSANY-UHFFFAOYSA-N Nc(c(F)c1)ccc1Br Chemical compound Nc(c(F)c1)ccc1Br GZRMNMGWNKSANY-UHFFFAOYSA-N 0.000 description 1
- AKCRQHGQIJBRMN-UHFFFAOYSA-N Nc1ccccc1Cl Chemical compound Nc1ccccc1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 1
- JLQNVOVFZSBPMY-UHFFFAOYSA-N O=C(C(C(NC1)=O)N(Cc2ccccc2)C1=O)NC1CCCCC1 Chemical compound O=C(C(C(NC1)=O)N(Cc2ccccc2)C1=O)NC1CCCCC1 JLQNVOVFZSBPMY-UHFFFAOYSA-N 0.000 description 1
- OADOLFWAQVQLQR-UHFFFAOYSA-N O=C(CNC1=O)[n]2c1cnc2 Chemical compound O=C(CNC1=O)[n]2c1cnc2 OADOLFWAQVQLQR-UHFFFAOYSA-N 0.000 description 1
- GTHUHSSKNGRNLO-UHFFFAOYSA-N OC(c1cccnc1NCCCC(c(cc1)ccc1F)=O)O Chemical compound OC(c1cccnc1NCCCC(c(cc1)ccc1F)=O)O GTHUHSSKNGRNLO-UHFFFAOYSA-N 0.000 description 1
- OLMIQEQJMIAHKC-UHFFFAOYSA-N OC(c1cccnc1NCCCC(c1ccccc1)=O)=O Chemical compound OC(c1cccnc1NCCCC(c1ccccc1)=O)=O OLMIQEQJMIAHKC-UHFFFAOYSA-N 0.000 description 1
- BCIBJNNTWWSBAL-UHFFFAOYSA-N OC(c1cccnc1NCCCC(c1ccccc1)=O)O Chemical compound OC(c1cccnc1NCCCC(c1ccccc1)=O)O BCIBJNNTWWSBAL-UHFFFAOYSA-N 0.000 description 1
- UEUZNHTYDBBLFR-UHFFFAOYSA-N OC(c1n[o]nc1NCCCC(c1ccccc1)=O)=O Chemical compound OC(c1n[o]nc1NCCCC(c1ccccc1)=O)=O UEUZNHTYDBBLFR-UHFFFAOYSA-N 0.000 description 1
- HFZYNLYAWMYTKB-UHFFFAOYSA-N OC(c1n[s]nc1NCCCC(c(cc1)ccc1F)=O)=O Chemical compound OC(c1n[s]nc1NCCCC(c(cc1)ccc1F)=O)=O HFZYNLYAWMYTKB-UHFFFAOYSA-N 0.000 description 1
- UTPNEQGSVYDXGH-UHFFFAOYSA-N OCCN(CCCC(c1ccccc1)O)c1n[o]nc1C(O)=O Chemical compound OCCN(CCCC(c1ccccc1)O)c1n[o]nc1C(O)=O UTPNEQGSVYDXGH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/22—Eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/38—Eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
FIELD: organic chemistry, medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to novel azaheterocycles of the general formula (I): possessing inhibitory effect on activity of tyrosine kinase and can be used in treatment of different diseases mediated by these receptors. In compound of the general formula (1) W represents azaheterocycle comprising 6-13 atoms that can be optionally annelated with at least one (C5-C7)-carbocycle and/or possibly annelated with heterocycle comprising 4-10 atoms in ring and comprising at least one heteroatom chosen from oxygen (O), sulfur (S) or nitrogen (N) atom; Ra 1 represents a substitute of amino group but not hydrogen atom, such as substituted (C1-C6)-alkyl, possibly substituted aryl and possibly substituted 5-10-membered heterocyclyl comprising at least one heteroatom chosen from O, S or N; Rb represents carbamoyl group -C(O)NHRa wherein Ra represents a substitute of amino group but not hydrogen atom, such as possibly substituted alkyl, possibly substituted aryl, possibly substituted 5-10-membered heterocyclyc comprising at least one heteroatom chosen from O, S or N; Rc represents a substitute of cyclic system, such as possibly substituted (C1-C6)-alkyl, possibly substituted aryl and possibly substituted 5-6-membered heterocyclyl comprising at least one heteroatom chosen from O, S or N; or Rb and Rc form in common aminocyanomethylene group [(=C(NH2)CN], or their pharmaceutically acceptable salts. Also, invention relates to methods for synthesis of these compounds (variants), a pharmaceutical composition, combinatory and focused libraries.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition, improved methods for synthesis and preparing.
35 cl, 16 sch, 13 tbl, 43 ex
Description
Claims (35)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006111951/04A RU2318818C1 (en) | 2006-04-12 | 2006-04-12 | Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) |
PCT/RU2007/000163 WO2007117180A1 (en) | 2006-04-12 | 2007-04-06 | Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006111951/04A RU2318818C1 (en) | 2006-04-12 | 2006-04-12 | Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007122661/04A Division RU2345078C1 (en) | 2007-06-19 | 2007-06-19 | Azaheterocycles, combinatorial library, focused library, pharmaceutical composition, method of obtaining |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006111951A RU2006111951A (en) | 2007-10-27 |
RU2318818C1 true RU2318818C1 (en) | 2008-03-10 |
Family
ID=38581378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006111951/04A RU2318818C1 (en) | 2006-04-12 | 2006-04-12 | Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU2318818C1 (en) |
WO (1) | WO2007117180A1 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8859538B2 (en) | 2007-06-21 | 2014-10-14 | Cara Therapeutics, Inc. | Uses of substituted imidazoheterocycles |
WO2008157751A2 (en) | 2007-06-21 | 2008-12-24 | Cara Therapeutics, Inc. | Substituted imidazoheterocycles |
US8124600B2 (en) | 2008-05-29 | 2012-02-28 | Albany Molecular Research, Inc. | 5-HT3 receptor modulators, methods of making, and use thereof |
EP2387567B1 (en) | 2009-01-14 | 2014-06-11 | The Salk Institute for Biological Studies | Compounds that protect against amyloid diseases |
KR20110132564A (en) | 2009-02-11 | 2011-12-08 | 선오비온 파마슈티컬스 인코포레이티드 | Histamine h3 inverse agonists and antagonists and methods of use thereof |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
AR077463A1 (en) | 2009-07-09 | 2011-08-31 | Irm Llc | IMIDAZO DERIVATIVES [1, 2 - A] PIRAZINA AND ITS USE IN MEDICINES FOR THE TREATMENT OF PARASITARY DISEASES |
CA2786089C (en) * | 2010-01-04 | 2014-04-15 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and agricultural fungicide |
WO2011153359A1 (en) | 2010-06-04 | 2011-12-08 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
WO2012173682A2 (en) * | 2011-03-29 | 2012-12-20 | The Broad Institute, Inc. | Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
US9453021B2 (en) | 2011-05-10 | 2016-09-27 | Kyowa Hakko Kirin Co., Ltd. | Pyrimidodiazepinone compound |
AR086411A1 (en) | 2011-05-20 | 2013-12-11 | Nippon Soda Co | HETEROCICLIC COMPOUND CONTAINING NITROGEN AND FUNGICIDE FOR USE IN AGRICULTURE AND GARDENING |
PE20221914A1 (en) | 2011-12-28 | 2022-12-23 | Global Blood Therapeutics Inc | SUBSTITUTE BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION |
EP2797597B1 (en) | 2011-12-28 | 2020-02-26 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
US9073931B2 (en) | 2012-03-16 | 2015-07-07 | Vitae Pharmaceuticals, Inc. | Liver X receptor modulators |
SG11201405328SA (en) | 2012-03-16 | 2014-11-27 | Vitae Pharmaceuticals Inc | Liver x receptor modulators |
EP2909214B1 (en) | 2012-10-22 | 2020-07-22 | City of Hope | Etp derivatives |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
KR101971385B1 (en) | 2013-03-15 | 2019-04-22 | 글로벌 블러드 테라퓨틱스, 인크. | Compounds and uses thereof for the modulation of hemoglobin |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN112500338A (en) | 2013-03-15 | 2021-03-16 | 全球血液疗法股份有限公司 | Compounds and their use for modulating hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
AU2014237330A1 (en) | 2013-03-15 | 2015-09-17 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EP3021847B1 (en) * | 2013-07-15 | 2023-06-07 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death |
EA201992707A1 (en) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION |
AU2015214182B2 (en) | 2014-02-07 | 2020-04-30 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
WO2016075137A1 (en) | 2014-11-10 | 2016-05-19 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death |
ES2747386T3 (en) * | 2015-01-14 | 2020-03-10 | Bristol Myers Squibb Co | Heteroarylene-linked benzodiazepine dimers, conjugates thereof and methods of preparation and use |
MA41841A (en) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | ALDEHYDE COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, HYPOXIA, AND AUTOIMMUNE AND CONNECTIVE TISSUE DISEASES |
CN104910176B (en) * | 2015-05-19 | 2017-05-10 | 西南大学 | Coumarin azole compound and preparation method therefor and application thereof |
MA43373A (en) | 2015-12-04 | 2018-10-10 | Global Blood Therapeutics Inc | DOSAGE REGIMES FOR 2-HYDROXY-6 - ((2- (1-ISOPROPYL-1H-PYRAZOL-5-YL) PYRIDIN-3-YL) METHOXY) BENZALDEHYDE |
TWI663160B (en) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde |
JP7088912B2 (en) | 2016-09-15 | 2022-06-21 | シティ・オブ・ホープ | Dithio ETP derivative |
TW202332423A (en) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
CN110691597A (en) | 2017-04-24 | 2020-01-14 | 诺华股份有限公司 | Therapeutic regimens for 2-amino-1- (2- (4-fluorophenyl) -3- (4-fluorophenylamino) -8, 8-dimethyl-5, 6-dihydroimidazo [1,2-a ] pyrazin-7 (8H) -yl) ethanones and combinations thereof |
JP2020524701A (en) * | 2017-06-22 | 2020-08-20 | サイクルニウム ファーマ インコーポレイテッド | Pyridine-containing macrocycle library and method for producing and using the same |
MX2020007532A (en) | 2018-01-19 | 2020-09-09 | Cytokinetics Inc | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors. |
JP7438148B2 (en) | 2018-06-26 | 2024-02-26 | サイトキネティックス, インコーポレイテッド | cardiac sarcomere inhibitor |
BR112021003496A2 (en) * | 2018-08-31 | 2021-05-18 | Cytokinetics, Inc. | compound, pharmaceutical composition, and, methods for treating heart disease, for treating a disease or condition associated with hypertrophic cardiomyopathy, or condition that is associated with secondary thickening of the left ventricular wall, or condition that is associated with the small cavity of the left ventricle and cavity obliteration, hyperdynamic contraction of the left ventricle, myocardial ischemia or cardiac fibrosis, or a condition selected from muscular dystrophies and glycogen storage diseases to inhibit cardiac sarcomere |
WO2020072377A1 (en) | 2018-10-01 | 2020-04-09 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
AR117169A1 (en) * | 2018-11-28 | 2021-07-14 | Bayer Ag | (TIO) PYRIDAZINE AMIDES AS FUNGICIDE COMPOUNDS |
CA3126334A1 (en) * | 2019-01-11 | 2020-07-16 | Shionogi & Co., Ltd. | Dihydropyrazolopyrazinone derivative having mgat2 inhibitory activity |
TW202110844A (en) * | 2019-06-04 | 2021-03-16 | 日商第一三共股份有限公司 | Dispiro-diketopiperazine compounds |
CN110551129B (en) * | 2019-07-23 | 2021-11-09 | 常州合全药业有限公司 | Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester |
JP2024508526A (en) | 2021-03-04 | 2024-02-27 | サイトキネティックス, インコーポレイテッド | cardiac sarcomere inhibitor |
CN113527321B (en) * | 2021-07-08 | 2022-06-28 | 金华职业技术学院 | Trifluoromethyl pyrazolo heptatomic ring compound, crystal structure and preparation method |
CN114574386B (en) * | 2022-03-01 | 2023-08-11 | 广东石油化工学院 | Bacillus licheniformis and application thereof |
CN114805343B (en) * | 2022-03-01 | 2023-06-30 | 广东石油化工学院 | Compound, preparation method and application thereof, and microorganism producing compound |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054579A (en) * | 1997-06-26 | 2000-04-25 | Leukosite, Inc. | Synthesis of substituted lactams |
EA003061B1 (en) * | 1998-01-29 | 2002-12-26 | Авентис Фармасьютикалз Инк. | Method for preparing an n-[(aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
US6723722B1 (en) * | 1999-06-22 | 2004-04-20 | Takeda Chemical Industries, Ltd. | Acylhydrazine derivatives, their production and use |
US7060698B2 (en) * | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
RU2266906C1 (en) * | 2004-04-29 | 2005-12-27 | Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") | Anellated carbamoyl azaheterocycles, methods for their preparing (variants), pharmaceutical composition, focused library |
-
2006
- 2006-04-12 RU RU2006111951/04A patent/RU2318818C1/en not_active IP Right Cessation
-
2007
- 2007-04-06 WO PCT/RU2007/000163 patent/WO2007117180A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
СА 109:144847:LURA RICHARD et al., Biochemistry, 1988, 27(20), 7671-7. CA 127:176409:NEFZI ADEL et al., Tetrahedron Letters, 1997, 38(28), 4943-4946. CA 142:56262:ACRITOPOULOU-ZANZE IRINI et al. Tetrahedron Letters, 2004, 45(46), 8439-8441. * |
Also Published As
Publication number | Publication date |
---|---|
WO2007117180A1 (en) | 2007-10-18 |
RU2006111951A (en) | 2007-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2318818C1 (en) | Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants) | |
Zagni et al. | The search for potent, small‐molecule HDACIs in cancer treatment: a decade after vorinostat | |
Horton et al. | The combinatorial synthesis of bicyclic privileged structures or privileged substructures | |
ES2672732T3 (en) | Prolines / substituted piperidines as orexin receptor antagonists | |
PT1704145E (en) | Selective kinase inhibitors | |
AU2007254179A1 (en) | Intracellular kinase inhibitors | |
AU2019246921B2 (en) | Novel kappa opioid ligands | |
UY29389A1 (en) | SUBSTITUTED ACID DERIVATIVES1 - ((4 - ((((3,3-DIMETIL-2-OXO-2,3-DIHIDRO-1H-INDOL-1-IL) CARBONIL) AMINO) METHYL) PIPERIDIN-1-IL) METHYL ) CYCLLOBUTANOCARBOXÍLICO, PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITIONS THAT CONTAIN THEM AND APPLICATIONS. | |
Barluenga et al. | Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of identified inhibitor | |
ES2617878T3 (en) | Tubulin inhibitors based on pyrazine | |
EA005128B1 (en) | Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them | |
EP2976077A1 (en) | Substituted benzimidazoles as nociceptin receptor modulators | |
TWI748491B (en) | 1,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
Wang et al. | Modular and stereoselective approach to highly substituted indole/pyrrole-fused diazepanones | |
CA2512243A1 (en) | N-aryl heteroaromatic products, compositions containing same and use thereof | |
Belov et al. | Guanidine‐Containing Phenyl‐Pyrrole Compounds as Probes for Generating HIV Entry Inhibitors Targeted to gp120 | |
FI94638C (en) | Process for the preparation of therapeutically useful 1-acyl-3- [4- (2-pyrimidinyl) -1-piperazinyl] propanes | |
Sañudo et al. | Synthesis of 3-hydroxy-6-oxo [1, 2, 4] triazin-1-yl alaninamides, a new class of cyclic dipeptidyl ureas | |
CN102574858A (en) | Bicyclic heterocycles and their use as CCR2 receptor antagonists | |
CN112533898A (en) | Heterocyclic compounds | |
EA017817B1 (en) | 3-ARYLSULFONYLPYRAZOLO[1,5-a]PYRIMIDINES - ANTAGONISTS OF SEROTONIN 5-HTRECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF | |
JPH01193264A (en) | 1-((5-(4-substituted-1-piperadinyl)methyl)-pyrrol -2-yl or fran-2-yl)methyl 2-piperadines effective for treatment of schizophrenia | |
Meirelles et al. | Synthesis of Nitrogen‐Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells | |
CN114206868A (en) | 3- (2- (heteroaryl) -pyridin-4-yl) -5- (trifluoromethyl) -1,2, 4-oxadiazole derivatives as HDAC6 inhibitors | |
CN101801975A (en) | Pyrazolo-pyrazines derivatives used as g protein inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090413 |